{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:59:01Z","timestamp":1781344741213,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["BBMRI-CZ LM2023033"],"award-info":[{"award-number":["BBMRI-CZ LM2023033"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014911","name":"Ministerstvo Obrany \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["MO1012"],"award-info":[{"award-number":["MO1012"]}],"id":[{"id":"10.13039\/501100014911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Female genital tract lesions with putative prostatic differentiation include vaginal tubulosquamous polyp (TSP), cervical ectopic prostatic tissue (EPT), and adenoid basal carcinoma (ABC). HoxB13 is a transcription factor specific for the prostate, not previously assessed in these lesions. A cohort of 13 TSPs, 6 EPTs, 17 ABCs, and 8 adenoid basal hyperplasia (ABH) was analyzed for expression of prostatic markers HoxB13, NKX3.1, p16, and androgen receptor (AR). Additional 28 cervical high-grade squamous intraepithelial lesions (HSILs), 21 cervical squamous cell carcinomas (SCCs), 19 endocervical adenocarcinomas (EACs), and 10 endometrial endometrioid adenocarcinomas (ECs) were included. The results were recorded as immunoreactive score (IRS). In TSPs and EPTs, HoxB13 and NKX3.1 were positive in 100% and 89.5% of cases, respectively. No HoxB13, NKX3.1, and p16 was observed in ABHs. In contrast, all ABCs showed diffuse p16 positivity. NKX3.1 was positive in 82.6% of ABCs (median IRS\u2009=\u20092), HoxB13 was positive in 100% of ABCs (median IRS\u2009=\u20098), and the difference was statistically significant (p\u2009&lt;\u20090.001). Both HoxB13 and NKX3.1 were positive in 9.5% (2\/21) SCCs and 21.1% (4\/19) EACs. Additionally, 40% (4\/10) ECs were HoxB13-positive (IRS\u2009=\u20091\u20132). Any positivity of HoxB13 was 80% specific and 100% sensitive for the ABC. NKX3.1 was only 82.4% sensitive, but 88% specific for the diagnosis of ABC. Additionally, HoxB13 was also seen in 29.8% HSILs. No ABC showed AR positivity, while this was observed in rare cells (IRS 1\u20132) in 30.8%, 16.6%, and 37.5% of TSCs, EPTs, and ABHs, respectively. HoxB13 can be a useful and reliable marker for identification of TSPs, EPTs and ABCs.<\/jats:p>","DOI":"10.1007\/s00428-025-04360-7","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:36:17Z","timestamp":1764743777000},"page":"1293-1302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of HoxB13 in differential diagnosis of female genital tract lesions with putative prostatic differentiation"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1021-1415","authenticated-orcid":false,"given":"Lucie","family":"Gerykova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hornychova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kamaradova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Trnkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Dundr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Matej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hrudka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Zalesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7169-4386","authenticated-orcid":false,"given":"Jiri","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"4360_CR1","unstructured":"Nguyen JD, Fakoya AO, Duong H\u00a0(2025) Anatomy, abdomen and pelvis: female external genitalia. [Updated 2025 Feb 15]. In: StatPearls [Internet]. Treasure island (FL): statPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547703\/"},{"key":"4360_CR2","volume-title":"Langman\u2019s medical embryology","author":"TW Sadler","year":"2019","unstructured":"Sadler TW (2019) Langman\u2019s medical embryology. Wolters Kluwer, Philadelphia"},{"key":"4360_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/PGP.0000000000000717","volume":"40","author":"R Hawari","year":"2021","unstructured":"Hawari R, Fernandes L, Park KJ, McCluggage WG (2021) Skene\u2019s gland derivatives in the female genital tract and cervical adenoid basal carcinoma are consistently positive with prostatic marker NKX3.1. Int J Gynecol Pathol 40:400\u2013407","journal-title":"Int J Gynecol Pathol"},{"key":"4360_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pathol.2020.07.011","volume":"53","author":"CJR Stewart","year":"2021","unstructured":"Stewart CJR, Moses J (2021) NKX3.1 expression in cervical \u2018adenoid basal cell carcinoma\u2019: another gynaecological lesion with prostatic differentiation? Pathology 53:193\u2013198","journal-title":"Pathology"},{"key":"4360_CR5","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1242\/dev.122.8.2475","volume":"122","author":"L Zeltser","year":"1996","unstructured":"Zeltser L, Desplan C (1996) Heintz N Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 122:2475\u20132484","journal-title":"Development"},{"key":"4360_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/path.6216","volume":"262","author":"RA Patel","year":"2024","unstructured":"Patel RA, Sayar E, Coleman I et al (2024) Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer. J Pathol 262:105\u2013120","journal-title":"J Pathol"},{"key":"4360_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.gendis.2017.01.003","volume":"4","author":"H Brechka","year":"2017","unstructured":"Brechka H, Bhanvadia RR, VanOpstall C (2017) Vander Griend DJ HOXB13 mutations and binding partners in prostate development and cancer: function, clinical significance, and future directions. Genes Dis 4:75\u201387","journal-title":"Genes Dis"},{"key":"4360_CR8","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/PAS.0b013e3181e6cbf3","volume":"34","author":"B Gurel","year":"2010","unstructured":"Gurel B, Ali TZ, Montgomery EA et al (2010) NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol 34:1097\u20131105","journal-title":"Am J Surg Pathol"},{"key":"4360_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/dvdy.10397","volume":"228","author":"MM Shen","year":"2003","unstructured":"Shen MM, Abate-Shen C (2003) Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 228:767\u2013778","journal-title":"Dev Dyn"},{"key":"4360_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molcel.2009.10.020","volume":"36","author":"JD Norris","year":"2009","unstructured":"Norris JD, Chang CY, Wittmann BM et al (2009) The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell 36:405\u2013416","journal-title":"Mol Cell"},{"key":"4360_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/ajcp\/aqz063","volume":"152","author":"Q Gan","year":"2019","unstructured":"Gan Q, Joseph CT, Guo M, Zhang M, Sun X, Gong Y (2019) Utility of NKX3.1 immunostaining in the detection of metastatic prostatic carcinoma on fine-needle aspiration smears. Am J Clin Pathol 152:495\u2013501","journal-title":"Am J Clin Pathol"},{"key":"4360_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061151","author":"I Kristiansen","year":"2017","unstructured":"Kristiansen I, Stephan C, Jung K et al (2017) Sensitivity of HOXB13 as a diagnostic immunohistochemical marker of prostatic origin in prostate cancer metastases: comparison to PSA, Prostein, androgen receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18061151","journal-title":"Int J Mol Sci"},{"key":"4360_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/pros.10210","volume":"55","author":"EP Gelmann","year":"2003","unstructured":"Gelmann EP, Bowen C, Bubendorf L (2003) Expression of NKX3.1 in normal and malignant tissues. Prostate 55:111\u2013117","journal-title":"Prostate"},{"key":"4360_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jclinpath-2014-202272","volume":"67","author":"RJ Asch-Kendrick","year":"2014","unstructured":"Asch-Kendrick RJ, Samols MA, Lilo MT et al (2014) Nkx3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. J Clin Pathol 67:768\u2013771","journal-title":"J Clin Pathol"},{"key":"4360_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000504810","volume":"87","author":"N Takada","year":"2020","unstructured":"Takada N, Nishida H, Oyama Y et al (2020) Immunohistochemical reactivity of prostate-specific markers for salivary duct carcinoma. Pathobiology 87:30\u201336","journal-title":"Pathobiology"},{"key":"4360_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.humpath.2018.09.009","volume":"84","author":"RK Yang","year":"2019","unstructured":"Yang RK, Zhao P, Lu C, Luo J, Hu R (2019) Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naive salivary duct carcinomas. Hum Pathol 84:173\u2013182","journal-title":"Hum Pathol"},{"key":"4360_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00428-013-1495-0","volume":"463","author":"J Varinot","year":"2013","unstructured":"Varinot J, Cussenot O, Roupret M et al (2013) HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. Virchows Arch 463:803\u2013809","journal-title":"Virchows Arch"},{"key":"4360_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/apm.12483","volume":"124","author":"V Barresi","year":"2016","unstructured":"Barresi V, Ieni A, Cardia R et al (2016) HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors. APMIS 124:188\u2013193","journal-title":"APMIS"},{"key":"4360_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00428-016-1946-5","volume":"469","author":"V Barresi","year":"2016","unstructured":"Barresi V, Ieni A, Reggiani Bonetti L, Tuccari G (2016) HOXB13 expression in metastatic prostate cancer. Virchows Arch 469:119\u2013120","journal-title":"Virchows Arch"},{"key":"4360_CR20","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.humpath.2012.03.023","volume":"43","author":"O Kerdraon","year":"2012","unstructured":"Kerdraon O, Cornelius A, Farine MO, Boulanger L, Wacrenier A (2012) Adenoid basal hyperplasia of the uterine cervix: a lesion of reserve cell type, distinct from adenoid basal carcinoma. Hum Pathol 43:2255\u20132265","journal-title":"Hum Pathol"},{"key":"4360_CR21","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W (1987) Stegner HE [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8:138\u2013140","journal-title":"Pathologe"},{"key":"4360_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12022-023-09779-9","volume":"34","author":"J Soukup","year":"2023","unstructured":"Soukup J, Manethova M, Stejskal V et al (2023) Immunoreactivity of HOXB13 in neuroendocrine neoplasms is a sensitive and specific marker of rectal well-differentiated neuroendocrine tumors. Endocr Pathol 34:333\u2013341","journal-title":"Endocr Pathol"},{"key":"4360_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00428-022-03441-1","volume":"482","author":"J Soukup","year":"2023","unstructured":"Soukup J, Manethova M, Kohout A et al (2023) Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors. Virchows Arch 482:325\u2013338","journal-title":"Virchows Arch"},{"key":"4360_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00401-025-02866-7","volume":"149","author":"S Purkait","year":"2025","unstructured":"Purkait S, Praeger S, Felsberg J et al (2025) Strong nuclear expression of HOXB13 is a reliable surrogate marker for DNA methylome profiling to distinguish myxopapillary ependymoma from spinal ependymoma. Acta Neuropathol 149:29","journal-title":"Acta Neuropathol"},{"key":"4360_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/PGP.0000000000000221","volume":"35","author":"A Goyal","year":"2016","unstructured":"Goyal A, Wang Z, Przybycin CG, Yang B (2016) Application of p16 immunohistochemistry and RNA in situ hybridization in the classification of adenoid basal tumors of the cervix. Int J Gynecol Pathol 35:82\u201391","journal-title":"Int J Gynecol Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04360-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:54:21Z","timestamp":1781344461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04360-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4360"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04360-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki and with the approval of the Ethics committee of the University Hospital Hradec Kralove (202403 P13 from 07\/03\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no conflict of interest. The preliminary results of this study were presented as poster (PS-17\u00a0012) at the 37th European Congress of Pathology held in Vienna, September 6\u201310, 2025.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}